Buy low, sell high: How we navigated the wild week on Wall Street
It was a tumultuous week for investors. President Donald Trump ‘s threat to increase tariffs on eight European countries for
Read More
Earnings
Cramer’s week ahead: Earnings from Meta, Microsoft and Apple. Plus, a Fed meeting
CNBC’s Jim Cramer alerted investors on Friday that next week will be a consequential one for Wall Street, pointing to
Read More
Intel stock drops 17%, its worst day since 2024, as manufacturing troubles overshadow
The Intel logo is seen at the India Mobile Congress 2025 in Delhi, Oct. 11, 2025. Kabir Jhangiani | Nurphoto
Read More
Capital One’s mixed quarter doesn’t change our view on its budding transformation
Shares of Capital One dipped on Thursday evening after the credit card issuer’s fourth-quarter earnings per share missed estimates due
Read More
Intel stock plunges 13% on soft guidance, concerns about chip production
The Intel logo is displayed on a sign in front of Intel headquarters on Jan. 22, 2026 in Santa Clara,
Read More
Procter & Gamble is selling diapers made with silk fibers in China as it leans into luxury
Packages of Pampers diapers are displayed at a Target store on June 05, 2025 in Novato, California. Justin Sullivan |
Read More
P&G’s weak quarter is a clearing event that sets the stage for a better year ahead
Procter & Gamble shares are rebounding from an early-morning decline following the company’s less-than-stellar results. We’re viewing the quarter as
Read More
Procter & Gamble earnings top estimates, but shrinking demand weighs on sales
Procter & Gamble on Thursday reported mixed quarterly results as demand for its Gillette razors and Pampers diapers fell. The
Read More
Netflix’s advertising strategy shift is starting to pay off
A drone view shows Netflix logos on buildings in the Hollywood neighborhood in Los Angeles, California, U.S., Jan. 20, 2026.
Read More
Johnson & Johnson forecasts 2026 profit above Wall Street estimates
Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to cut drug
Read More